Standard Care | Low Risk

BENZETHONIUM CHLORIDE AND BENZOCAINE (Medi-first Protective Coating Bandage)

What to know about BENZETHONIUM CHLORIDE AND BENZOCAINE — also sold as Medi-first Protective Coating Bandage: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

BENZETHONIUM CHLORIDE AND BENZOCAINE (brand names: Medi-first Protective Coating Bandage) is classified as Low risk (1 risk points) by AllMeds. It is a S3 medication under the TGA in Australia. FDA approved in the United States. Topical antimicrobial with local anaesthetic having minimal workplace safety impact.

Key Takeaways

  • TGA Schedule: S3 in Australia
  • Risk level: Low (1 points)
  • Recommended maximum duration: 14 days

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S3 Not PBS listed
United States (FDA) Rx only FDA approved

Risk Profile

Risk Level Low
Risk Points 1
CNS Depressant No
Respiratory Risk No
Max Duration 14 days

Topical antimicrobial with local anaesthetic having minimal workplace safety impact.

How BENZETHONIUM CHLORIDE AND BENZOCAINE is regulated

BENZETHONIUM CHLORIDE AND BENZOCAINE is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Australia TGA / PBS / State Schemes

Classified as S3 under the Therapeutic Goods Administration (TGA).

United States FDA / CDC / State WC

FDA approved for use in the United States.

Check this medication against your full medication list

Run a full risk assessment including BENZETHONIUM CHLORIDE AND BENZOCAINE interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.